PREVIOUS
✖
Lumpy Skin Disease Vaccine – Biolumpivaxin
February 18 , 2025
3 days
145
0
- The Bharat Biotech group firm Biovet has received the Central Drug Standards Control Organization (CDSCO) licence for the lumpy skin disease (LSD) vaccine – BIOLUMPIVAXIN.
- It was developed in collaboration with the Indian Council of Agriculture Research (ICAR).
- It is used for dairy cattle and buffaloes Biolumpivaxin.
- This is the first Differentiation of Infected from Vaccinated Animals (DIVA) marker vaccine globally for LSD.
- Lumpy Skin Disease (LSD) was first detected in India in July 2019 in Odisha and later spread to 20 states by the end of 2020.
- The disease affects cattle and Asian water buffaloes.
- It is spread by insects and causes a significant loss of milk production.
- India is the world’s largest milk producer, contributing over 22% of global milk production, followed by the EU-28 and the United States.
Leave a Reply
Your Comment is awaiting moderation.